Literature DB >> 8943092

In vivo modulation of vincristine-induced neurotoxicity in Lymnaea stagnalis, by the ACTH(4-9) analogue Org 2766.

B Kiburg1, C Moorer-van Delft, J J Heimans, P C Huijgens, H H Boer.   

Abstract

The use of the cytostatic agent vincristine (VCR) is limited by the occurrence of peripheral neuropathy. This side-effect is probably caused by interference with axonal microtubules. VCR depolymerizes microtubules and reacts with tubulin to form paracrystals. The potential of a neurotrophic ACTH(4-9) analogue, Org 2766, to counteract peripheral neuropathy caused by cytostatic agents is being investigated. In the present ultrastructural study, modulatory effects of Org 2766 on VCR-induced neurotoxicity were studied in vivo in neurons of the pond snail Lymnaea stagnalis, which has been shown previously to be a suitable test system to investigate neurotoxic side-effects of cytostatic agents. 24 h after treatment with VCR (25 microM), 68.4 +/- 34.7 paracrystals were counted per cross-section of the cerebral commissure and the number of microtubules in the axons had been lowered to 46% of the control level. After a survival period of two weeks all paracrystals had disappeared. By that time, no recovery of the axonal microtubular system could be observed. However, post-treatment with Org 2766 (10(-6) M) on day 6 after VCR treatment had induced a significant increase in the number of microtubules (+55%) on day 7. This beneficial effect lasted for the rest of the experimental period (14 days). These results suggest that post-treatment with Org 2766, i.e. after VCR clearance, can induce long-lasting beneficial effects on VCR-induced neurotoxicity in vivo.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8943092     DOI: 10.1007/bf00177268

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  27 in total

Review 1.  Neuropeptide hormones as neurotrophic factors.

Authors:  F L Strand; K J Rose; L A Zuccarelli; J Kume; S E Alves; F J Antonawich; L Y Garrett
Journal:  Physiol Rev       Date:  1991-10       Impact factor: 37.312

2.  The pharmacokinetics of [3H]-vincristine in man.

Authors:  R A Bender; M C Castle; D A Margileth; V T Oliverio
Journal:  Clin Pharmacol Ther       Date:  1977-10       Impact factor: 6.875

3.  Paracrystalline inclusions in optic nerve terminals following intraocular injection of vinblastine.

Authors:  A H Bunt
Journal:  Brain Res       Date:  1973-04-13       Impact factor: 3.252

4.  Vincristine-induced neuropathy. A clinical study of fifty leukemic patients.

Authors:  S G Sandler; W Tobin; E S Henderson
Journal:  Neurology       Date:  1969-04       Impact factor: 9.910

5.  Efficacy of the neuropeptide ORG.2766 in the prevention and treatment of cisplatin-induced neurotoxicity in rats.

Authors:  R Gerritsen van der Hoop; P de Koning; E Boven; J P Neijt; F G Jennekens; W H Gispen
Journal:  Eur J Cancer Clin Oncol       Date:  1988-04

6.  Effects of ORG 2766, a neurotrophic ACTH4-9 analogue, in neuroblastoma cells.

Authors:  R Murry; J A McLane; G Gruener
Journal:  Ann N Y Acad Sci       Date:  1993-05-28       Impact factor: 5.691

7.  Differential trophic effects of ORG 2766, an ACTH(4-9)/MSH(4-9) analogue, on peptidergic neurons and glial cells in the snail Lymnaea stagnalis.

Authors:  L J Müller; B Kiburg; C M Moorer-van Delft; H H Boer
Journal:  Peptides       Date:  1994-01       Impact factor: 3.750

8.  Instability of pleomorphic tubulin paracrystals artificially induced by Vinca alkaloids in tissue-cultured cells.

Authors:  H Takanari; T Yosida; J Morita; K Izutsu; T Ito
Journal:  Biol Cell       Date:  1990       Impact factor: 4.458

9.  Prevention of cisplatin neurotoxicity with an ACTH(4-9) analogue in patients with ovarian cancer.

Authors:  R G van der Hoop; C J Vecht; M E van der Burg; A Elderson; W Boogerd; J J Heimans; E P Vries; J C van Houwelingen; F G Jennekens; W H Gispen
Journal:  N Engl J Med       Date:  1990-01-11       Impact factor: 91.245

10.  A pilot study on the influence of a corticotropin (4-9) analogue on Vinca alkaloid-induced neuropathy.

Authors:  B van Kooten; H A van Diemen; K M Groenhout; P C Huijgens; G J Ossenkoppele; J J Nauta; J J Heimans
Journal:  Arch Neurol       Date:  1992-10
View more
  3 in total

Review 1.  Microtubule-binding agents: a dynamic field of cancer therapeutics.

Authors:  Charles Dumontet; Mary Ann Jordan
Journal:  Nat Rev Drug Discov       Date:  2010-10       Impact factor: 84.694

2.  Chemotherapy related fatal neurotoxicity during induction in acute lymphoblastic leukemia.

Authors:  Munni Ray; R K Marwaha; Amita Trehan
Journal:  Indian J Pediatr       Date:  2002-02       Impact factor: 1.967

3.  Lack of neuroprotection by an ACTH (4-9) analogue. A randomized trial in patients treated with vincristine for Hodgkin's or non-Hodgkin's lymphoma.

Authors:  S Koeppen; C C P Verstappen; R Körte; M E Scheulen; D Strumberg; T J Postma; J J Heimans; P C Huijgens; B Kiburg; K Renzing-Köhler; H C Diener
Journal:  J Cancer Res Clin Oncol       Date:  2004-01-16       Impact factor: 4.553

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.